Barclays Maintains Equal-Weight on CME Group, Lowers Price Target to $343

Benzinga Newsdesk www.benzinga.com Negative 75.3%

Neg 75.3% Neu 0% Pos 0%

Barclays analyst Benjamin Budish maintains CME Group (NASDAQ:CME) with a Equal-Weight and lowers the price target from $344 to $343.